To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More

For anyone looking to invest in the casino industry, the Chinese city of Macau has been — and will likely continue to be — the opportunity of a lifetime. When looking to invest in Macau gaming, many investors gravitate toward U.S.-based operators such as Las Vegas Sands… Read More

If you haven’t noticed, the IPO market is on fire.  As has been the case for a number of months, the most recent crop of newly public companies are posting stellar after-market gains. With the exception of a tepid after-market performance for data storage firm Violin Memory (Nasdaq: VMEM), the… Read More

The investment world is full of old wives’ tales, outright falsehoods and ideas that make sense in theory but fail time and again when put into practice.  One such falsehood is the belief that the big money players such as hedge funds and institutions never lose money. Nothing could be… Read More

There are currently more than 118,000 people in the U.S. waiting for a lifesaving organ transplant. But if a group of groundbreaking scientists has its way, that number will soon be zero. In a massive medical and technological breakthrough, scientists are now successfully producing living human kidneys with a mind-bending… Read More

I love it when a raging bull market pulls back. The steeper the pullback, the more I like it.  Obviously, this has its limits, but money is made by buying low and selling high in the stock market. Short-term profit-taking in strong individual stocks and mostly bogus economic fears are… Read More

I’m a big fan of buying stocks that have recently hit a new all-time high. Clearly they have strong momentum, but the main reason is that, because there is no overhead resistance, they often go higher. And when that bullish chart is supported… Read More

Making a profit in the restaurant business is tough. Of the 153 companies listed in the industry on Yahoo Finance, only 90 are profitable.  Even the success stories have to contend with razor-thin margins and net profits averaging just a dime for every dollar of sales. If you can build… Read More

Cast your net where the big fish swim. — Anonymous Who hasn’t dreamed of buying and selling stocks alongside the most successful investors of all time? I’m talking about big fish like Warren Buffett, hedge fund manager George Soros and activist investor Carl Icahn. (Let the record show that the… Read More